HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Emilio Russo Selected Research

Sirolimus (Rapamycin)

11/2014Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release.
11/2014The mTOR signaling pathway and neuronal stem/progenitor cell proliferation in the hippocampus are altered during the development of absence epilepsy in a genetic animal model.
6/2013mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Emilio Russo Research Topics

Disease

72Seizures (Absence Seizure)
06/2022 - 02/2003
70Epilepsy (Aura)
06/2022 - 02/2003
27Absence Epilepsy (Childhood Absence Epilepsy)
05/2022 - 09/2005
11Neoplasms (Cancer)
03/2020 - 05/2009
10Rheumatoid Arthritis
01/2018 - 01/2013
8Drug-Related Side Effects and Adverse Reactions
01/2020 - 02/2013
7Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2016
7Inflammation (Inflammations)
04/2021 - 04/2015
7Status Epilepticus (Complex Partial Status Epilepticus)
11/2019 - 06/2011
6Cognitive Dysfunction
05/2022 - 01/2016
5Neuroinflammatory Diseases
10/2021 - 11/2014
5Temporal Lobe Epilepsy
08/2020 - 01/2015
5Insulin Resistance
04/2018 - 05/2015
4Psoriasis (Pustulosis Palmaris et Plantaris)
05/2021 - 12/2013
4Stroke (Strokes)
01/2021 - 04/2013
4Brain Diseases (Brain Disorder)
01/2021 - 04/2015
4Mental Disorders (Mental Disorder)
04/2020 - 06/2013
4Nervous System Diseases (Neurological Disorders)
11/2017 - 09/2012
4Multiple Sclerosis
01/2017 - 04/2013
3Generalized Epilepsy
05/2022 - 10/2018
3Idiopathic Generalized Epilepsy
05/2022 - 12/2016
3Chronic Renal Insufficiency
01/2022 - 01/2016
3Chronic Kidney Failure (Chronic Renal Failure)
05/2021 - 01/2018
3Sleepiness
01/2021 - 01/2021
3Hypoglycemia (Reactive Hypoglycemia)
12/2020 - 01/2018
3Fibrosis (Cirrhosis)
01/2020 - 09/2011
3Pain (Aches)
01/2020 - 06/2013
3Psoriatic Arthritis
01/2018 - 12/2013
3Hippocampal Sclerosis
11/2017 - 01/2015
3Reflex Epilepsy (Photosensitive Epilepsy)
12/2016 - 03/2016
3Parkinson Disease (Parkinson's Disease)
11/2016 - 04/2013
3Schizophrenia (Dementia Praecox)
01/2015 - 09/2007
2Autosomal Dominant Polycystic Kidney (ADPKD)
01/2022 - 01/2021
2Cysts
01/2022 - 01/2021
2Hypertension (High Blood Pressure)
11/2021 - 09/2019
2Ulcerative Colitis
07/2021 - 01/2019
2Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
07/2021 - 01/2020
2Gastrointestinal Diseases (Functional Gastrointestinal Disorders)
05/2021 - 01/2021
2Obesity
01/2021 - 11/2020
2Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2021 - 01/2021
2Atrial Fibrillation
01/2021 - 01/2015

Drug/Important Bio-Agent (IBA)

36Pharmaceutical PreparationsIBA
05/2022 - 08/2008
34Anticonvulsants (Antiepileptic Drugs)IBA
08/2020 - 02/2003
11perampanelIBA
02/2022 - 03/2014
11AMPA Receptors (AMPA Receptor)IBA
01/2020 - 05/2004
8Antidepressive Agents (Antidepressants)IBA
06/2022 - 07/2011
8Insulin (Novolin)FDA Link
12/2020 - 01/2016
8alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
01/2020 - 02/2003
7CannabidiolIBA
01/2022 - 01/2016
7Glucose (Dextrose)FDA LinkGeneric
11/2020 - 01/2016
7Valproic Acid (Depakote)FDA LinkGeneric
01/2020 - 02/2013
6Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2015
6Antipsychotic Agents (Antipsychotics)IBA
05/2021 - 09/2008
6Biological ProductsIBA
04/2020 - 01/2017
5Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
04/2020 - 04/2013
5Pentylenetetrazole (Metrazol)IBA
01/2019 - 02/2003
5AcidsIBA
01/2018 - 02/2003
4brivaracetamIBA
02/2022 - 01/2015
4Metformin (Glucophage)FDA LinkGeneric
01/2022 - 01/2016
4Adrenal Cortex Hormones (Corticosteroids)IBA
05/2021 - 12/2013
4Butyric Acid (Butanoic Acid)IBA
01/2020 - 01/2019
4Kainic Acid (Kainate)IBA
11/2019 - 02/2003
4Levetiracetam (Keppra)FDA LinkGeneric
10/2019 - 08/2010
4Carbamazepine (Tegretol)FDA LinkGeneric
05/2018 - 07/2011
4Abatacept (Orencia)FDA Link
04/2018 - 12/2013
4Complement C3 (C3 Complement)IBA
01/2018 - 01/2016
4CannabinoidsIBA
11/2017 - 09/2013
4Tryptases (Tryptase)IBA
10/2015 - 01/2013
3Immunoglobulin E (IgE)IBA
05/2022 - 03/2016
3LacosamideFDA Link
02/2022 - 01/2016
3CenobamateIBA
02/2022 - 01/2021
3methylglyoxal bis(3-aminopropylamidinohydrazone)IBA
01/2022 - 01/2021
3Transaminases (Aminotransferases)IBA
01/2021 - 12/2014
3CytokinesIBA
10/2020 - 11/2014
3SuspensionsIBA
10/2020 - 08/2014
3Fatty Acids (Saturated Fatty Acids)IBA
01/2020 - 06/2013
3Glucagon-Like Peptide 1 (GLP 1)IBA
01/2020 - 01/2016
3Histone Deacetylases (Histone Deacetylase)IBA
01/2020 - 01/2017
3Ethosuximide (Zarontin)FDA LinkGeneric
10/2019 - 08/2008
3Methotrexate (Mexate)FDA LinkGeneric
01/2018 - 01/2013
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2018 - 01/2015
3Peroxisome Proliferator-Activated Receptors (PPAR)IBA
11/2016 - 06/2013
3Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
01/2016 - 12/2012
3TOR Serine-Threonine KinasesIBA
01/2016 - 06/2013
3Sirolimus (Rapamycin)FDA Link
11/2014 - 06/2013
3Lamotrigine (Lamictal)FDA LinkGeneric
10/2013 - 02/2013
32- acetyl- 1- (4'- chlorophenyl)- 6,7- dimethoxy- 1,2,3,4- tetrahydroisoquinolineIBA
08/2008 - 01/2004
2Duloxetine Hydrochloride (Cymbalta)FDA Link
06/2022 - 06/2015
2Fluoxetine (Prozac)FDA LinkGeneric
06/2022 - 06/2015
2Sertraline (Zoloft)FDA LinkGeneric
06/2022 - 01/2016
2Glutamic Acid (Glutamate)FDA Link
05/2022 - 01/2020
2eslicarbazepine acetateIBA
02/2022 - 12/2017
2PrebioticsIBA
01/2022 - 10/2021
2ixekizumabIBA
05/2021 - 01/2020
2MineralsIBA
04/2021 - 01/2021
2Cathepsin KIBA
04/2021 - 01/2021
2AnticoagulantsIBA
01/2021 - 01/2018
2edoxabanIBA
01/2021 - 01/2018

Therapy/Procedure

37Therapeutics
05/2022 - 05/2012
6Aftercare (After-Treatment)
05/2021 - 04/2015